Clinuvel Pharmaceuticals | CUV - Operating Profit

Stock Price
9.47
Daily Change
-0.19 -1.97%
Monthly
-18.85%
Yearly
-20.29%
Q1 Forecast
9.72

Clinuvel Pharmaceuticals reported AUD39.05M in Operating Profit for its fiscal semester ending in June of 2024.





Operating Profit Change Date
Avita Medical AUD -10.41M 742K Dec/2025
Medical Developments International AUD -36K 444K Dec/2025
Mesoblast USD -42.11M 21.69M Jun/2025
Neuren Pharmaceuticals AUD 17.01M 11.56M Dec/2025
Pacific Edge NZD -19.4M 2.91M Dec/2025
Paradigm Biopharmaceuticals AUD -8.5M 2.57M Jun/2025
PYC Therapeutics AUD -22.59M 9.12M Dec/2025
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025